Oversea-Chinese Banking Corp (OCBC)’s American Healthcare REIT AHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.55M Sell
144,735
-34,246
-19% -$1.68M 0.16% 107
2026
Q1
$8.44M Sell
178,981
-6,492
-4% -$322K 0.23% 89
2025
Q4
$8.73M Sell
185,473
-21,969
-11% -$1.02M 0.23% 74
2025
Q3
$8.71M Sell
207,442
-1,977
-0.9% -$79.5K 0.21% 82
2025
Q2
$7.69M Sell
209,419
-2,406
-1% -$80K 0.21% 83
2025
Q1
$6.42M Sell
211,825
-26,771
-11% -$772K 0.18% 99
2024
Q4
$6.78M Buy
238,596
+35,830
+18% +$964K 0.19% 95
2024
Q3
$5.29M Buy
202,766
+13,257
+7% +$258K 0.15% 113
2024
Q2
$2.77M Hold
189,509
0.08% 150
2024
Q1
$2.8M Buy
+189,509
New +$2.6M 0.08% 154

Other funds holding AHR

Oversea-Chinese Banking Corp (OCBC)'s AHR Position: Q2 2026 in Review

Oversea-Chinese Banking Corp (OCBC) reduced its American Healthcare REIT (AHR) stake by 19% in Q2 2026, selling an estimated $1.68M and leaving 144,735 shares worth $7.55M. The position accounts for 0.16% of the portfolio, ranked #107.

Oversea-Chinese Banking Corp (OCBC) first reported a position in AHR in Q1 2024 and has held it in 10 quarters since. The position peaked at $8.73M in Q4 2025. 314 funds tracked by Wall St. Rank hold AHR as of Q2 2026.

  • Oversea-Chinese Banking Corp (OCBC) held 144,735 shares of American Healthcare REIT worth $7.55M as of Q2 2026.
  • Oversea-Chinese Banking Corp (OCBC) sold 34,246 American Healthcare REIT shares in Q2 2026, an estimated $1.68M.
  • American Healthcare REIT made up 0.16% of Oversea-Chinese Banking Corp (OCBC)'s portfolio in Q2 2026, its #107 holding.
  • Oversea-Chinese Banking Corp (OCBC) first reported a position in American Healthcare REIT in Q1 2024 and has held it in 10 quarters since.
  • Oversea-Chinese Banking Corp (OCBC)'s American Healthcare REIT position peaked at $8.73M in Q4 2025.
  • 314 funds tracked by Wall St. Rank held American Healthcare REIT as of Q2 2026.

Based on Oversea-Chinese Banking Corp (OCBC)'s 13F filing for Q2 2026, filed 11 Aug 2026.